JOHNSON & JOHNSON (JNJ)
US4781601046 - Common Stock
JOHNSON & JOHNSON
NYSE:JNJ (12/20/2024, 8:20:30 PM)
Premarket: 144.99 +0.52 (+0.36%)144.47
+0.89 (+0.62%)
Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 131,900 full-time employees. The firm's primary focus is products related to human health and well-being. The company operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).
Company Info
JOHNSON & JOHNSON
One Johnson & Johnson Plaza
New Brunswick NEW JERSEY 08933
P: 17325242455
CEO: A. Gorsky
Employees: 131900
Website: https://www.jnj.com/
JNJ News
3 days ago - EIN PresswireNeuropathic Pain Market Set to Witness Significant Growth by 2024-2031 | Pfizer, Inc., Johnson & Johnson ServicesGlobal Neuropathic Pain Market is estimated to valued at US$ 7.56 Billion in 2023 and expected to exhibit a CAGR of 6.2% during the forecast period 2023-2030
5 days ago - The Motley FoolThe Smartest Dividend Stocks to Buy With $500 Right Now5 days ago - Yahoo FinanceThe Smartest Dividend Stocks to Buy With $500 Right NowIf you add a few dividend stocks to your portfolio, you'll start collecting returns on a regular basis -- without lifting a finger. Loads of companies pay dividends, so it might seem difficult make a selection. A great way to start is to consider the list of Dividend Kings, companies that have increased their dividend payments for at least 50 consecutive years.
6 days ago - Zacks Investment ResearchJohnson & Johnson (JNJ) Stock Declines While Market Improves: Some Information for InvestorsIn the most recent trading session, Johnson & Johnson (JNJ) closed at $143.85, indicating a -1.89% shift from the previous trading day.
10 days ago - Yahoo FinanceJ&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reportsJohnson & Johnson has sued divisions of Cigna, accusing the health insurer of working with a drug-benefit middleman to drain J&J's financial-assistance funds earmarked for patients taking some of its pricier drugs, The Wall Street Journal reported on Friday.
10 days ago - Market News VideoFriday 12/13 Insider Buying Report: PLAY, JNJJNJ Twits
Here you can normally see the latest stock twits on JNJ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
